Norges Bank
CADX

Norges Bank’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

Norges Bank’s Portfolio CADX Stock Details CADX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-479,154
Closed -$4.34M – 2122
2013
Q4 		$4.34M Hold
479,154
– – ﹤0.01% 1934
2013
Q3 		$3.02M Hold
479,154
– – ﹤0.01% 2010
2013
Q2 		$3.27M Buy
+479,154
New +$3.34M ﹤0.01% 1988

Other funds holding CADX

OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Norges Bank's CADX Position: Q1 2014 in Review

Norges Bank sold out of CADENCE PHARMACEUTICALS, INC COM STK (CADX) in Q1 2014, closing a stake of 479,154 shares — an estimated $4.34M sold.

Norges Bank first reported a position in CADX in Q2 2013 and held it in 3 quarters. The position peaked at $4.34M in Q4 2013. 3 funds tracked by Wall St. Rank hold CADX as of Q1 2014.

  • Norges Bank reported no remaining CADENCE PHARMACEUTICALS, INC COM STK position as of Q1 2014 after selling out during the quarter.
  • Norges Bank sold 479,154 CADENCE PHARMACEUTICALS, INC COM STK shares in Q1 2014, an estimated $4.34M.
  • Norges Bank first reported a position in CADENCE PHARMACEUTICALS, INC COM STK in Q2 2013 and held it in 3 quarters.
  • Norges Bank's CADENCE PHARMACEUTICALS, INC COM STK position peaked at $4.34M in Q4 2013.
  • 3 funds tracked by Wall St. Rank held CADENCE PHARMACEUTICALS, INC COM STK as of Q1 2014.

Based on Norges Bank's 13F filing for Q1 2014, filed 9 May 2014.